Indications for portal pressure measurement in chronic liver disease

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 8-9, 2012, Pages 887-892

  Hobolth, Lise ^a   Bendtsen, Flemming ^a   Moller, Soren ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cirrhosis; Indications; Portal hypertension

Indexed keywords

ANTIVIRAL THERAPY; ASCITES; BLOOD PRESSURE MEASUREMENT; CHRONIC LIVER DISEASE; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; PRESSURE GRADIENT; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; SURVIVAL PREDICTION; TREATMENT INDICATION; TREATMENT RESPONSE; UPPER GASTROINTESTINAL BLEEDING; VEIN CATHETERIZATION;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHRONIC DISEASE; HUMANS; HYPERTENSION, PORTAL; LIVER DISEASES; PORTAL VEIN;

EID: 84865747300     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.706827     Document Type: Review

References (30)

1. de FR, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5: 645-63.
2. Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Dig Liver Dis 2008;40: 328-36.
3. Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008;57: 268-78.
4. Moller S, Henriksen JH, Bendtsen F. Ascites: pathogenesis and therapeutic principles. Scand J Gastroenterol 2009;44: 902-11.
5. Cardenas A, Gines P. Portal hypertension. Curr Opin Gastroenterol 2009;25: 195-201.
6. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346: 1056-9.
7. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32: 930-4.
8. Bureau C, Peron JM, Alric L, Morales J, Sanchez J, Barange K, et al. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002; 36: 1361-6.
9. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37: 902-8.
10. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004;39: 280-2.
11. Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis 2005;37: 601-8.
12. Zipprich A, Winkler M, Seufferlein T, Dollinger MM. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther 2010;32: 1351-6.
13. Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002;37: 960-4.
14. Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006;26: 348-62.
15. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117: 626-31.
16. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. 1. Gastroenterology 2006;131: 1611-24.
17. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133: 481-8.
18. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50: 923-8.
19. Kim MY, Baik SK, Yea CJ, Lee IY, Kim HJ, Park KW, et al. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol 2009;21: 1241-6.
20. Hobolth L, Krag A, Bendtsen F. The recent reduction in mortality from bleeding oesophageal varices is primarily observed from days 1 to 5. Liver Int 2010;30: 455-62.
21. Burroughs AK, Triantos CK, O'Beirne J, Patch D. Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis. Nat Clin Pract Gastroenterol Hepatol 2009;6: 72-3.
22. Bendtsen F, Simonsen L, Henriksen JH. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. Gastroenterology 1992;102: 1017-23.
23. Garcia-Pagan JC, De GA, Bosch J. Review article: the modern management of portal hypertension-primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 2008;28: 178-86.
24. Bendtsen F, Henriksen JH, Sorensen TI. Propranolol and haemodynamic response in cirrhosis. J Hepatol 1991;13: 144-8.
25. Klein CP, Kalk JF, Muting D, Klein CG. The effect of alcohol on portal vein hemodynamics in nutritional-toxic liver cirrhosis. Dtsch Med Wochenschr 1993;118: 89-93.
26. Villanueva C, Aracil C, Colomo A, Hernandez-Gea V, Lopez-Balaguer JM, varez-Urturi C, et al. Acute hemody-namic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009;137: 119-28.
27. La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, Garcia-Pagan JC, et al. Prognostic value of acute hemody-namic response to i. v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol 2009;51: 279-87.
28. de FR. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53: 762-8.
29. Thalheimer U, Bellis L, Puoti C, Burroughs AK. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Eur J Intern Med 2011;22: 5-7.
30. Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, et al. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol 2011;9: 602-8.